Global lead investigator, TALAPRO-3
Appears in 1 story
Presented the final results at ASCO 2026
About one in four men with advanced prostate cancer carry inherited flaws in the genes that repair damaged DNA. A large trial now shows that giving those men a targeted pill alongside standard hormone therapy delays the cancer's spread by a wide margin.
Updated Jul 30
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
